Thus, the inhibition of the RIG-I/IFN response by ZIKV NS5 is thought to be key to ensuring the viral cycle and the infection of cells found in immunoprivileged sites, such as the brain or placenta [71,194], thereby allowing ZIKV evasion of IFN-mediated innate immunity. The gene discussed is IFNA1; the disease is infection.